AGIOS PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $640.5M | $80.9M |
| FY2020 | — | $399.5M | $127.4M |
| FY2021 | — | $1.29B | $203.1M |
| FY2022 | — | $1.10B | $139.3M |
| FY2023 | — | $811.0M | $88.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $640.5M | $80.9M |
| FY2020 | — | $399.5M | $127.4M |
| FY2021 | — | $1.29B | $203.1M |
| FY2022 | — | $1.10B | $139.3M |
| FY2023 | — | $811.0M | $88.2M |